Follow Us On:
Ensuring high standards in clinical trial audits through expert assessment, regulatory compliance, and alignment with global best practices to maintain quality at every step.
The reliability of electronic data is utmost important in the digital age. CurexBio leverages cutting-edge EDC systems for clinical trials as a cornerstone of our quality and compliance strategy. These systems are not just for data capture; they are integral tools for ensuring high-quality, auditable, and secure clinical data.
Our chosen EDC systems for clinical trials are fully compliant with 21 CFR Part 11, the FDA regulation governing electronic records and electronic signatures. This ensures that all electronic data collected is trustworthy, reliable, and equivalent to paper records, providing an undeniable audit trail and enhancing the acceptability of your data by regulatory agencies.
CurexBio EDC system undergoes diligent data validation checks, ensuring real-time uniformity and range checks at data entry. This proactive validation minimizes errors and inconsistencies. Every action within the EDC system is documented in a comprehensive audit trail, ensuring regulatory scrutiny and transparency of clinical trial data, thereby ensuring accountability.
Our EDC systems prioritize the security of clinical trial data by implementing robust measures like user access controls, data encryption, and secure backups. Integral query management system accelerates organized communication between sites and data managers, allowing instant resolution of errors and quality compliance.
We offer an array of niche and full-fledged CRO services, from clinical trial protocol development to post-marketing surveillance. Streamline Your Drug Development with Curexbio CRO Expertise
Quality compliance in clinical trials refers to ensuring that all processes, data, and documentation follow global regulatory standards such as FDA and ICH-GCP guidelines. It ensures that clinical data is accurate, reliable, and audit-ready, helping maintain patient safety and regulatory acceptance.
21 CFR Part 11 compliance ensures that electronic records and signatures are secure, traceable, and equivalent to paper records. This regulation helps maintain data integrity, provides audit trails, and ensures that clinical trial data is accepted by regulatory authorities worldwide.
CurexBio ensures data integrity through advanced EDC systems, real-time data validation checks, secure data handling, and comprehensive audit trails. These systems minimize errors, enhance transparency, and maintain high-quality, compliant clinical data throughout the trial lifecycle.
Clinical trial audits are systematic reviews of trial processes, data, and documentation to ensure compliance with regulatory standards. They help identify gaps, ensure protocol adherence, and prepare organizations for regulatory inspections, reducing risks and delays in approvals.
CurexBio provides comprehensive quality compliance services including QA audits, regulatory readiness assessments, data validation, audit trail management, and compliance support for Phase I–IV clinical trials, RWE, and HEOR studies

1113, Silver Radiance 4 Sarkhej – Gandhinagar Hwy, Chanakyapuri, Ahmedabad, Gujarat 382481

7851 SW Ellipse Way Suite 16 Stuart, Florida 34997

203 Ziadodda Cresent, Brampton,Ontario, L6P1T4
© Copyright 2025 Curexbio. All Rights Reserved